MetaDeq Diagnostics
Pre-clinicalRedefining Liver Health Through Early Detection and Monitoring: A Paradigm Shift HeparDx: A blood test for MASH and Liver Fibrosis focused on detecting lobular inflammation and hepatocyte ballooning In June 2023, the American Diabetes Association Recommended that all Type 2 Diabetes patients are screened for MASLD (NAFLD). In June 2023, the multinational liver societies AASLD, … Home Read More »
About
Redefining Liver Health Through Early Detection and Monitoring: A Paradigm Shift HeparDx: A blood test for MASH and Liver Fibrosis focused on detecting lobular inflammation and hepatocyte ballooning In June 2023, the American Diabetes Association Recommended that all Type 2 Diabetes patients are screened for MASLD (NAFLD). In June 2023, the multinational liver societies AASLD, … Home Read More »
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile